What is Werewolf Therapeutics, Inc. Common Stock's Market Cap?

Werewolf Therapeutics, Inc. Common Stock's Market Cap is $47.6M, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's Enterprise Value?

Werewolf Therapeutics, Inc. Common Stock's Enterprise Value is $57.7M, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's EV / EBITDA?

Werewolf Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's Net Income (TTM)?

Werewolf Therapeutics, Inc. Common Stock's Net Income (TTM) is -$34.6M, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's EBITDA?

Werewolf Therapeutics, Inc. Common Stock's EBITDA is -$27.6M, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Werewolf Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.71, based on as-reported figures from SEC (XBRL) filings.

What is Werewolf Therapeutics, Inc. Common Stock's Net Debt?

Werewolf Therapeutics, Inc. Common Stock's Net Debt is $10.1M, based on as-reported figures from SEC (XBRL) filings.

Werewolf Therapeutics, Inc. Common Stock (HOWL) Financial Statements

Werewolf Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00QXQ9XL3

XNAS · usd

0.98▲ 0.01 (1.42%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.97

Day's Range0.94 – 0.99

52-Week Range0.27 – 2.38

Volume662.5K

Avg Volume11.5M

Share Statistics

Shares Outstanding

Employees39

ExchangeXNAS

Listed2021-04-30

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Werewolf Therapeutics, Inc. Common Stock (HOWL)

What is Werewolf Therapeutics, Inc. Common Stock's Market Cap?: Werewolf Therapeutics, Inc. Common Stock's Market Cap is $47.6M, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's Enterprise Value?: Werewolf Therapeutics, Inc. Common Stock's Enterprise Value is $57.7M, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's EV / EBITDA?: Werewolf Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's Net Income (TTM)?: Werewolf Therapeutics, Inc. Common Stock's Net Income (TTM) is -$34.6M, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's EBITDA?: Werewolf Therapeutics, Inc. Common Stock's EBITDA is -$27.6M, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Werewolf Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.71, based on as-reported figures from SEC (XBRL) filings.
What is Werewolf Therapeutics, Inc. Common Stock's Net Debt?: Werewolf Therapeutics, Inc. Common Stock's Net Debt is $10.1M, based on as-reported figures from SEC (XBRL) filings.